“There is ample reason for Microsoft to slow the rush to buy health IT, despite the fact it’s a member of the plan’s chief advocate.
Microsoft is in no position to take full advantage.
While Microsoft does have a stake in this market through Amalga, and its Healthvault PHR operation, it is not yet ready for prime time.”
Article
Dana Blankenhorn, ZDNet Healthcare, 15 January 2009
